Save information for later
Sign Up

Learn About Epilepsy Juvenile Absence

What is the definition of Epilepsy Juvenile Absence?
Juvenile absence epilepsy (JAE) is a genetic epilepsy with onset occurring around puberty. JAE is characterized by sporadic occurrence of absence seizures, frequently associated with a long-life prevalence of generalized tonic-clonic seizures (GTCS) and sporadic myoclonic jerks.
What are the alternative names for Epilepsy Juvenile Absence?
  • Epilepsy juvenile absence
  • Childhood absence epilepsy
  • JAE
  • Juvenile absence epilepsy
Who are the top Epilepsy Juvenile Absence Local Doctors?
Elite in Epilepsy Juvenile Absence
Elite in Epilepsy Juvenile Absence

Yale University

800 Howard Ave, 
New Haven, CT 
Languages Spoken:
English

Hal Blumenfeld is a Neurologist in New Haven, Connecticut. Dr. Blumenfeld is rated as an Elite provider by MediFind in the treatment of Epilepsy Juvenile Absence. His top areas of expertise are Absence Seizure, Seizures, Epilepsy Juvenile Absence, Epilepsy, and Deep Brain Stimulation.

Terrance P. Snutch
Elite in Epilepsy Juvenile Absence
Elite in Epilepsy Juvenile Absence
Vancouver, BC, CA 

Terrance Snutch practices in Vancouver, Canada. Mr. Snutch is rated as an Elite expert by MediFind in the treatment of Epilepsy Juvenile Absence. His top areas of expertise are Epilepsy Juvenile Absence, Sporadic Hemiplegic Migraine, Absence Seizure, and Epilepsy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Epilepsy Juvenile Absence
Elite in Epilepsy Juvenile Absence
Nijmegen, GE, NL 

Gilles Van Luijtelaar practices in Nijmegen, Netherlands. Mr. Van Luijtelaar is rated as an Elite expert by MediFind in the treatment of Epilepsy Juvenile Absence. His top areas of expertise are Epilepsy Juvenile Absence, Absence Seizure, Epilepsy, Seizures, and Deep Brain Stimulation.

What are the latest Epilepsy Juvenile Absence Clinical Trials?
A Single-center, Double-blind, Placebo-controlled Crossover Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures

Summary: This study will compare the effect of NPT 2042 and placebo in subjects with GGE on the frequency and duration of electroencephalographic absence seizures, separated by a 14-day washout period. The study will be a single-center, double-blind, crossover study with subjects receiving either NPT 2042 80 mg BID orally or matching placebo BID in each of two treatment periods.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomized, Dose-Finding and Confirmatory, Double-Blind, Placebo-Controlled, Parallel-Group Multicenter Study With a 2 Stage Adaptive Design and Randomized Withdrawal to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Summary: The purpose of the study is to test the efficacy, safety and tolerability of brivaracetam monotherapy in study participants 2 to 25 years of age inclusive with childhood absence epilepsy (CAE) or juvenile absence epilepsy (JAE).

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center